GenoTwin
PrivateLast Round
Accelerator
Oct 14, 2022
Company Overview
GenoTwin operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was an Accelerator round in October 2022.
GenoTwin is a biotechnology company that provides a genomics platform combining AI and computational biology to address infectious disease challenges and pathogen surveillance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenoTwin Comparables
Compare GenoTwin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Barnwell Bio | 85% | |
| metaBIX Biotech | 81% | |
| DARO | 78% |
For institutional investors. Book with your work email.
GenoTwin Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
GenoTwin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2022
Plug and Play Tech Center led the funding round.
For institutional investors. Book with your work email.
GenoTwin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenoTwin's valuation, stock price, and market status.
Is GenoTwin a public or private company?
GenoTwin is a private company.
What is the current stock price of GenoTwin?
GenoTwin is a private company, so its shares have no public market price. Caplight tracks GenoTwin's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenoTwin worth (valuation)?
Valuation information for GenoTwin is not publicly available.
Can I buy GenoTwin stock?
GenoTwin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenoTwin's last funding round?
GenoTwin's most recent funding round was Accelerator on October 14, 2022.
Who are the main investors in GenoTwin?
Key investors in GenoTwin include Plug and Play Tech Center.
Will GenoTwin IPO soon?
No public IPO plans have been announced for GenoTwin.
How can I track GenoTwin secondary market activity?
Caplight tracks bids, offers, and trades in GenoTwin's shares on secondary markets.